A study to assess correlation between weight loss medications and the development of cirrhosis and HCC in an obese population
Latest Information Update: 23 Dec 2021
At a glance
- Drugs Liraglutide (Primary) ; Lorcaserin (Primary) ; Naltrexone/bupropion (Primary) ; Orlistat (Primary) ; Phentermine/topiramate (Primary)
- Indications Obesity
- Focus Adverse reactions
- 23 Dec 2021 New trial record
- 27 Oct 2021 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2021